Clinical trialNCT06042153Active, not recruitingPhase 4Interventional

DIALYSIS-TIR Study

SponsorUniversity of Texas Southwestern Medical CenterEnrollment43End Stage Renal Disease on DialysisType 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide to people taking "dummy" medicine. The treatment participants get will be decided randomly. Participants will need to inject the study medication once a week. The study will last for 1 year and a month. Participants will be asked to wear a sensor that measures blood sugar levels for a period of 10 days at five different time points during the study.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Ildiko Lingvay, MD, MPH, MSCS
University of Texas Southwestern Medical Center
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of North Carolina
Chapel Hill, North Carolina, United States
Davita Ut Southwestern - East Dallas
Dallas, Texas, United States
Davita Ut Southwestern - Preston
Dallas, Texas, United States
Davita Ut Southwestern - Oak Cliff
Dallas, Texas, United States
Davita Ut Southwestern - Irving
Irving, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboSemaglutide →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Dec 2023
Primary completion: 30 Sept 2027
Completion: 30 Sept 2028
Last update posted: 13 Jan 2026
Registered enrollment: 43
Registry id: NCT06042153

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.